Head and neck squamous cell carcinomas responded better to a combination of two immunotherapies than to one immunotherapy ...
Guttman-Yassky received research support, consulting, or lecture fees on atopic dermatitis from Regeneron, Sanofi, Pfizer, ...
Mestag Therapeutics, a leading biotech company specialising in fibroblast immunology for inflammatory disease and cancer, has ...
During a live event, Alexander I. Spira, MD, PhD, and participants discuss efficacy, adverse events, and sequencing of EGFR-mutated NSCLC treatments.
In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune, buying its drug-development pipeline for $15.2 billion. However many analysts felt the company had paid far too much ...
Excitement builds for CAA championships in D.C. © 2025 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site ...
After hours: March 11 at 4:32:18 PM EDT Loading Chart for VIR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback